<DOC>
	<DOCNO>NCT02050737</DOCNO>
	<brief_summary>This exploratory , translational , non-interventional multi-centre clinical study .</brief_summary>
	<brief_title>Plasma Biomarkers C-RAC , ICORG 12-27 , V1</brief_title>
	<detailed_description>Cohort A consist 100 CRAC patient stage II/III resectable disease due adjuvant chemotherapy . Cohort B consist 30 patient stage II resectable disease observation . Both cohort follow period 2 year , post chemotherapy cohort A post resection cohort B .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Patient must able give write informed consent Histologically cytologically confirm CRAC Cohort A : colorectal cancer patient stage II/III resectable disease due adjuvant chemotherapy OR Cohort B : colorectal cancer patient stage II resectable disease observation Age â‰¥ 18 year Treatment curative intent Eastern Cooperative Oncology Group ( ECOG ) Performance status 0 2 Presence medical psychiatric condition , , opinion investigator , would potentially pose risk patient participate trial Evidence metastatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Curative resection</keyword>
	<keyword>Adjuvant chemotherapy</keyword>
</DOC>